Reported Reactions

Devices › System, imaging, pulsed echo, ultrasonic

Device brand name · System imaging pulsed echo ultrasonic

Galaxy Intravascular Ultrasound System: medical device reports filed with FDA

969 reports name it, 2012–2018. Manufacturer given most often on reports: Boston Scientific - Fremont Sud. Product code IYO.

969
device reports naming the brand
0% of all MAUDE reports · about 70 a year
0
reports, 12 months to August 2026
0 in the 12 months before
98.9%
classified as malfunction
95.3% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 969 reports that name the brand "Galaxy Intravascular Ultrasound System" (system imaging pulsed echo ultrasonic), received between September 2012 and July 2018; the manufacturer given most often on reports is Boston Scientific - Fremont Sud. Spellings of one product vary from report to report.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.9%) and injury (1.1%); across all system, imaging, pulsed echo, ultrasonic reports (product code IYO) death is recorded in 0.3% and malfunction in 95.3%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are retraction problem (98.9%), device contamination with chemical or other material (0.3%) and device operates differently than expected (0.2%). The patient problems coded most often are no patient involvement, thrombus and obstruction/occlusion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Galaxy Intravascular Ultrasound System was received in the five years to August 2026; the latest was received in July 2018.

By year received

01332652012: 1420122013: 26520132014: 20920142015: 20120152016: 10720162017: 10320172018: 702018

Event type and report source

Event type, as classified on the report

Death0%0
Injury1.1%11
Malfunction98.9%958
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%969
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 6,553 reports carrying product code IYO. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Retraction problem95898.9%15.8%
Device contamination with chemical or other material30.3%0%
Device operates differently than expectedthe device behaved unexpectedly20.2%1.2%
Device packaging compromised20.2%0%
Application program problem10.1%0.1%
Breakthe device broke10.1%5%
Communication or transmission problemthe device could not communicate or transmit10.1%0%
Device displays incorrect message10.1%0.6%
Material deformation10.1%0%
No display/image10.1%2.2%
Noise, audible10.1%0.2%
Operating system becomes nonfunctional10.1%0.2%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
No patient involvement12012.4%
Thrombus111.1%
Obstruction/occlusion101%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGalaxy Intravascular Ultrasound SystemProduct code IYOAll MAUDE reports
Reports9696,55326,136,888
Share of that pool—14.8%0%
Classified as death, per 1,000 reports039
Classified as injury1.1%3.7%36.2%
Classified as malfunction98.9%95.3%62.3%
Filed by the manufacturer100%97.8%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code IYO

BrandReportsLatest 12 monthsClassified as death
Site-Rite 8 Ultrasound73500%
Site Rite 8 Ultrasound System 20mm Cue Linear Probe49000%
Site Rite 8 Ultrasound System Console With Connector40000%
Acuson69100.4%
Site~Rite 8 Ultrasound System3121120%
Site-Rite 8 Ultrasound Systsem Console Remanufactured22400%
iLab Ultrasound Imaging System1,075850.2%
ACUSON SC2000 Ultrasound System221110%
ViewFlex Xtra ICE Catheter418661.2%
Bard Tl Cvc Catheter21300%
Autoclavable Camera Head320550%
Toshiba15801.9%
Powerpicc Solo Catheter With Sherlock 3cg Tps Stylet 4f Full Tray30900%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Galaxy Intravascular Ultrasound System reports

How many FDA reports name Galaxy Intravascular Ultrasound System?

969 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (98.9%) and injury (1.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

retraction problem (98.9%), device contamination with chemical or other material (0.3%), device operates differently than expected (0.2%), device packaging compromised (0.2%) and application program problem (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Galaxy Intravascular Ultrasound System was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.